Close  

DOH pushes for VAT exempt cancer medications

/ 01:40 PM January 16, 2019

MANILA, Philippines—After the removal of the value-added tax (VAT) on medicines for diabetes, hypertension and high cholesterol, the Department of Health (DOH) said it is now working for the tax exemption of cancer medications.

DOH Undersecretary Eric Domingo announced this on Wednesday during a briefing in Malacañang, noting that the Health department has been receiving “strong clamor” for the exemption of cancer medicines.

ADVERTISEMENT

“‘Yung TRAIN law limited lang talaga doon sa tatlo, anti-hypertensive, anti-diabetic and anti-cholesterol (medicines), pero ang strong clamor natin ngayon, which we are discussing with an inter-agency working group, ay ‘yung gamot para sa cancer,” Domingo said.

“We have very strong patient groups and mga NGOs (Non-government Organizations) na talagang working with us and tinitignan natin kung paano maisasama itong cancer medicines (sa VAT exemptions),” he added.

FEATURED STORIES

The tax exemption of medicines for diabetes, high cholesterol and hypertension started this year due to a provision of the Tax Reform for Acceleration and Inclusion (TRAIN) law.

The TRAIN law has allowed the government to collect more taxes from other products and services and finance more programs for health, education, and social assistance for indigent citizens.

President Rodrigo Duterte signed the TRAIN law on December 19, 2017. /muf

READ: VAT-free diabetes, hypertension meds starting 2019 — DOF

Read Next
LATEST STORIES
MOST READ
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Cancer, Cholesterol, Diabetes, DoH, Eric Domingo, Health, hypertension, Local news, Malacañang, Nation, national news, news, Philippine news update, TRAIN law, VAT
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2019 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.